Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (601-610 of 831) with videos related to

Pageof 84
Sort By:
Neuro-Oncology|March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO groupNorbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.
Neuro-Oncology|July 8, 2022
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactionsMarcel Buehler, Xiao Yi, Weigang Ge, et al.
Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.
Neuro-Oncology|August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working GroupRaymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Neuro-Oncology Advances|May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastomaMustafa Khasraw, Michael Weller, David Lorente, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour groupJohnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
Pageof 84

Showing results (601-610 of 831) with videos related to

Sort By:
Pageof 84
Neuro-Oncology|March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO groupNorbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.
Neuro-Oncology|July 8, 2022
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactionsMarcel Buehler, Xiao Yi, Weigang Ge, et al.
Archives of Pathology & Laboratory Medicine|June 21, 2019
Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer ReportingDavid N Louis, Pieter Wesseling, Sebastian Brandner, et al.
Neuro-Oncology|August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working GroupRaymond Y Huang, Wenya Linda Bi, Michael Weller, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Neuro-Oncology Advances|May 31, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastomaMustafa Khasraw, Michael Weller, David Lorente, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour groupJohnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
Pageof 84